Pharmaceutical News

RSS

Historic study that evidenced the benefits of anti-COVID steroids could have saved lives

A study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.

18 Aug 2020

When a SARS-CoV-2 vaccine arrives, who should be vaccinated first?

This new study by the researchers at Fred Hutchinson Cancer Research Center and the University of Washington, Tacoma and published on the preprint server medRxiv in August 2020 describes one viewpoint concerning the optimized allocation of the vaccine, showing that under different efficacy scenarios, either the old or the young may be the best candidates for initial vaccination.

18 Aug 2020

Other forms of treatments are as effective as opioids for acute musculoskeletal injuries

Two new evidence reviews related to acute musculoskeletal injuries like strains and sprains suggest other forms of treatments are as effective as opioids and have less risk of harms to patients.

18 Aug 2020

FDA approves drug for treatment of neuromyelitis optica spectrum disorder

The U.S. Food and Drug Administration has approved Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults with a particular antibody - patients who are anti-aquaporin-4 or AQP4 antibody-positive.

17 Aug 2020

Back-pain patients taking opioid painkillers produce anti-opioid antibodies

University of Wisconsin-Madison scientists have discovered that a majority of back-pain patients they tested who were taking opioid painkillers produced anti-opioid antibodies.

17 Aug 2020

Governments urged to ensure access to controlled medicines during COVID-19 pandemic

The International Narcotics Control Board (INCB), the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) call on governments to ensure that the procurement and supply of controlled medicines in countries meet the needs of patients, both those who have COVID-19 and those who require internationally controlled medicines for other medical conditions.

14 Aug 2020

Search engines can spread false information on vaccines, shows study

Anti-vaccine websites, which could play a key role in promoting public hesitancy about a potential COVID vaccine, are far more likely to be found via independent search engines than through an internet giant like Google.

14 Aug 2020

Pharmacy teams still not receiving adequate COVID-19 risk assessments, survey finds

A new survey carried out by the Royal Pharmaceutical Society and the UK Black Pharmacists Association has found that pharmacy teams are still not receiving adequate individual COVID-19 risk assessments.

13 Aug 2020

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.

13 Aug 2020

Bayer supports WHO through donated medicines for treatment of T. solium infection

A recent agreement between the World Health Organization and the German pharmaceutical company Bayer promises hope of expanding access to essential medicines for the treatment of people exposed to or infected by the pork tapeworm Taenia solium.

12 Aug 2020

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

Today, the U.S. Food and Drug Administration granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.

12 Aug 2020

Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood

A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.

12 Aug 2020

Using medieval medicine to find new treatments for modern-day infections

News-Medical spoke to researchers from the University of Warwick about their research investigating natural antimicrobials and their potential as antibiotics.

11 Aug 2020

Opioid risk is higher for patients transitioning to skilled nursing facilities

Hospital patients discharged to skilled nursing facilities often bring a high-dose painkiller prescription with them, suggesting more attention should be paid to opioid safety for those patients, research from the Oregon State University College of Pharmacy shows.

11 Aug 2020

Finland joins international organization dedicated to COVID-19 vaccines

The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country's accession to IVI.

11 Aug 2020

First-time opioid prescriptions may lead to substance-related problems later in life

Young adults and adolescents who are prescribed opioids for the first time may be at a slightly greater risk of developing a substance-related problem later in life, according to a new study co-authored by Indiana University researchers.

11 Aug 2020

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.

11 Aug 2020

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

As the coronavirus vaccine race charges on, many of the investigational candidate vaccines are nearing the final stages of human trials. The results of these trials will determine if they will be granted the green light to manufacture and distribute the vaccine to countries across the globe.

10 Aug 2020

FDA approves opioid agonist for management of moderate to severe acute pain in adults

Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.

9 Aug 2020

FDA approves first oral drug for treatment of spinal muscular atrophy

The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.

7 Aug 2020

Pharmaceutical News

Historic study that evidenced the benefits of anti-COVID steroids could have saved lives

When a SARS-CoV-2 vaccine arrives, who should be vaccinated first?

Other forms of treatments are as effective as opioids for acute musculoskeletal injuries

FDA approves drug for treatment of neuromyelitis optica spectrum disorder

Back-pain patients taking opioid painkillers produce anti-opioid antibodies

Governments urged to ensure access to controlled medicines during COVID-19 pandemic

Search engines can spread false information on vaccines, shows study

Pharmacy teams still not receiving adequate COVID-19 risk assessments, survey finds

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

Bayer supports WHO through donated medicines for treatment of T. solium infection

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood

Using medieval medicine to find new treatments for modern-day infections

Opioid risk is higher for patients transitioning to skilled nursing facilities

Finland joins international organization dedicated to COVID-19 vaccines

First-time opioid prescriptions may lead to substance-related problems later in life

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

FDA approves opioid agonist for management of moderate to severe acute pain in adults

FDA approves first oral drug for treatment of spinal muscular atrophy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News